Agilent Technologies to present at TIDES conference

PALO ALTO, Calif., May 1, 2006, Agilent Technologies Inc. (NYSE: A) today announced that Kenneth W. Hill, Ph.D., will speak at the TIDES 2006 conference on May 3 in Carlsbad, Calif. His presentation is part of Agilent’s participation in this annual conference on oligonucleotide and peptide technology, focusing on product development for therapeutics and diagnostics.

Hill will speak about “Considerations for Preparation of Conjugated Oligonucleotide Drug Substances.” The presentation focuses on improvements in manufacturing processes for PEGylated synthetic nucleic acids, which may play an increasing role in developing optimal oligonucleotide-based drugs.

Hill is part of Agilent’s Boulder, Colo., organization, which Agilent acquired on April 17, 2006. The facility manufactures short, synthetic DNA and RNA molecules that are becoming more important to the pharmaceutical and biotech industries as components of drugs for use in clinical trials. The organization is headed by General Manager James Powell.

More information about Agilent’s Boulder, Colo., organization is available at www.agilent.com/about/newsroom/presrel/2006/01may-gp06014.pdf

For product information, please contact Bridgette Bergin at +1 303 222 4900, or e-mail pdl-boulderinfo@agilent.com.
About Agilent Technologies

Agilent Technologies, Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. The company’s 20,000 employees serve customers in more than 110 countries. Agilent had net revenue of $5.1 billion in fiscal year 2005. Information about Agilent is available on the Web at www.agilent.com.

Contact Information

Michele Drake

Agilent Technologies, Inc.

Contact via E-mail